Published guidelines/recommendations for the off-label use of recombinant human activated factor VII, including warfarin-associated coagulopathy
| Society (year) . | Recommendations . |
|---|---|
| SABM/UHC (2005)99 | Appropriate for spontaneous or traumatic intracranial bleeding in patients on warfarin |
| EU societies (2006)100 | Patients on warfarin anticoagulation not addressed |
| Northern Ireland (2007)101 | If on-going significant hemorrhage after correction of clotting factor deficiencies |
| ASH (2008)94 | Not indicated |
| Society (year) . | Recommendations . |
|---|---|
| SABM/UHC (2005)99 | Appropriate for spontaneous or traumatic intracranial bleeding in patients on warfarin |
| EU societies (2006)100 | Patients on warfarin anticoagulation not addressed |
| Northern Ireland (2007)101 | If on-going significant hemorrhage after correction of clotting factor deficiencies |
| ASH (2008)94 | Not indicated |
SABM/UHC indicates Society for Advancement of Blood Management/University Hospitals Consortium; EU, European Union; and ASH, American Society of Hematology.